Latest Breaking News On - Guangzhou fill - Page 1 : comparemela.com

Focuses on the Consolidation for Leading Projects Accelerates Clinical Trials for Core Products STP705, STP707 and STP122G HONG KONG, Germantown, Md. and SUZHOU, China, March 28, 2024 /PRNewswire/.

United statesPatrick luGroup galaheadPrnewswire sirnaomics ltdSirnaomics ltdDrug administrationLeading projectsClinical trialsCore productsInvestigational new drug applicationResponse evaluation criteriaGuangzhou fillExecutive directorChief executive officerof sirnaomicsStock code